Company Analysis

EyePoint, Inc. (EYPT)

Nasdaq: EYPT · Laboratory Analytical Instruments · Watertown, MA · filing with the SEC since 2005
Grade3.9
◀ Past 3.4● Present 3.5▶ Future 4.7
1 est.

Who runs EyePoint, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Duker Jay S.
President and CEO. First filing Sep 2016, latest Jul 14, 2026, 2 filings in all.
Officers reporting now
4
of 11 people with a filing in the last fifteen months
Directors reporting now
7
30 people on the record since 2007
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Elston GeorgeChief Financial OfficerNov 2019Aug 24, 2026none
Duker Jay S.President and CEOSep 2016Jul 14, 2026none
Ribeiro RamiroChief Medical OfficerMar 2024Jul 2, 20267 · $900,000
Lurker NancyExecutive Vice ChairSep 2016Jan 7, 20263 · $200,000
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Zaderej Karen L.directorJul 2022Aug 18, 2026none
Ando GorandirectorJun 2018Jan 6, 2026none
Dicicco Wendy FdirectorJul 2019Jan 6, 2026none
Duty StuartdirectorOct 2023Jan 6, 2026none
Hassan FreddirectorSep 2024Jan 6, 2026none
Landis John B.directorOct 2018Jan 6, 2026none
Sanders Reginald J.directorJan 2025Jan 6, 2026none
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Chen Bihua10% ownerDec 2023Dec 8, 2025none
Cormorant Asset Management, LP10% ownerDec 2023Dec 8, 20251 · $900,000
Cormorant Global Healthcare Master Fund, LP10% ownerDec 2023Dec 8, 2025none
Earlier names on the record26, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton EYPT · research, not advice